exclusive – Page 2 – Retraction Watch

Exclusive: Cancer researcher sues MD Anderson over misconduct finding

A biochemist who worked as a postdoc at The University of Texas MD Anderson Cancer Center in Houston has sued the institution to dispute findings of research misconduct.

The researcher, Sonia Melo, now at the University of Porto in Portugal, alleges MD Anderson did not follow its own policies while conducting its investigation. Melo lost a prestigious grant in 2016 after one of her papers was retracted for containing duplicated images.

MD Anderson’s investigation concerned a paper published in Cancer Cell in 2014. On August 7 the journal marked it with a “temporary Expression of Concern” detailing duplicated and relabeled data found in the probe, which was completed in May 2024. The article has been cited 1,462 times, according to Clarivate’s Web of Science.

Exclusive: U.S. federal research integrity teams take hits with departures

Amid efforts by the Trump administration to “put an end to fraudulent and wasteful spending” and “enhance” accountability, two key offices charged with investigating fraud and holding scientists and institutions accountable for federal spending have seen top leadership depart.

At the National Science Foundation’s Office of Inspector General (OIG), the changes start at the top: Inspector General Allison Lerner is departing, and Megan Wallace, currently assistant inspector general for investigations at NSF, will become the acting inspector general, effective March 1.

Deputy Inspector General Ken Chason is also departing. The acting deputy will be Catherine DelPrete, who is NSF’s general counsel to NSF’s inspector general, according to her LinkedIn profile.

The changes were confirmed by Nadine Lymn, communications director of the National Science Board, which appoints and supervises NSF’s inspector general.

Meanwhile, Retraction Watch has learned that most — if not all — research investigators at the National Science Foundation’s Office of the Inspector General (OIG) will also be leaving their jobs.

Exclusive: Extensive correction to Genentech PNAS article will get an update after RW inquiry

An article by Genentech scientists received an extensive correction in January for multiple instances of image duplications after comments on PubPeer spurred the authors to review the work.

But the correction “inadvertently omitted” an additional duplication, and will be updated after Retraction Watch brought the matter to the journal’s attention, a representative for the publication said. The sleuth who identified the additional duplication said the original article should have been retracted instead of corrected.

The article, “Death-receptor activation halts clathrin-dependent endocytosis,” appeared in July 2006 in Proceedings of the National Academy of Sciences, with a correction issued that September. It has been cited 99 times, according to Clarivate’s Web of Science.

Exclusive: Researcher who received settlement to leave University of Iowa won’t be starting new job

A cardiology researcher who left the University of Iowa with a six-figure settlement earlier this year won’t be starting the new job he’d lined up at the Providence VA Medical Center, Retraction Watch has learned.

Justyn Charon, a spokesperson for the Providence VA, previously told us the researcher, Kaikobad Irani, would begin his new position “around November.” When we followed up, Charon confirmed, “there is currently no plan for Dr. Irani to be employed by VA Providence.”

In the meantime, the University of Iowa in Iowa City has launched an investigation about the leak of a report regarding Irani to Retraction Watch that appears to be an attempt to identify the source of the document.

Exclusive: New hijacking scam targets Elsevier, Springer Nature, and other major publishers

Until recently, journal hijackers do not appear to have targeted titles from big publishers, in part because their well-known website designs made such clones easy to detect.

Typically, cloned versions of journals’ websites are of low quality and don’t resemble the recognizable and professional designs of Springer Nature and Elsevier. As described in previous posts, fraudulent publishers would usually copy the ISSN, title and other metadata of niche and university journals in order to avoid identification, and possibly index their unauthorized content in bibliographic databases such as Scopus or Web of Science.

We’ve cataloged over 300 such cloned journals in the Retraction Watch Hijacked Journal Checker, a small number of which involve major publishers like Springer Nature, Elsevier and Wiley. For example, earlier this year the Journal of Academic Ethics and Machine Intelligence Research, both published by Springer Nature, were cloned.

But earlier this month, William Black, founder and CEO of PSIref, an online platform aggregating scholarly publication data which offers advertising opportunities for publishers, sent me evidence of a new, more sophisticated scam.

Exclusive: Cancer researchers in Iran under investigation as questions swirl around dozens of studies

Year after year, a husband-and-wife team at a university in Iran has been publishing studies involving research on cell lines ostensibly purchased from the Pasteur Institute of Iran, in Tehran.

But the couple may never have been in possession of the cells. In correspondence obtained by Retraction Watch, the Pasteur Institute told their employer, Jahrom University of Medical Sciences, only three of the many cell lines described in their publications had been available at the national cell bank over the past decade.

A university official confirmed the two researchers – Fraidoon Kavoosi, an associate professor in the department of anatomical science, and his wife Masumeh Sanaei, an assistant professor in the same department – were under investigation.

Exclusive: Editorial board member quits over journal’s handling of plagiarized paper

An architecture journal’s “failure to act in a timely and proactive manner” in a case of plagiarism in a now-retracted review article has sparked the resignation of a member of its editorial board, Retraction Watch has learned.

“I am appalled that it took, essentially, from November 2022 until now, September 2024, to resolve what was a fairly straightforward matter,” Dirk H. R. Spennemann, of Charles Sturt University in Albury, Australia, wrote in a Sept. 18, 2024, email to the editor-in-chief of Buildings, an MDPI title.

The offending paper, “A Review on Building Design as a Biomedical System for Preventing COVID-19 Pandemic,” was published in April 2022 in a special issue Spennemann had edited.

But in June of that year, Marco Spada, a senior lecturer in architecture at the University of Suffolk in the United Kingdom, informed Buildings the work borrowed heavily from two previous publications without proper citation. Although many sentences had been reworded using synonyms, the plagiarism was extensive and obvious.

Spada had recognized the article, a version of which he had previously reviewed – and rejected – as a referee for Sustainability, a different MDPI journal. Elements such as the title, the order in which the authors appeared and some of the abstract had changed, Spada told us. But it was still the same paper.

“Clearly they managed to outsmart the system,” Spada said.

Exclusive: Providence VA hires scientist previous employer found had harassed mentees

The University of Iowa found a cardiology researcher violated multiple of its policies, including harassing his former mentees when they tried to leave his lab to establish labs of their own, according to an investigation report obtained by Retraction Watch.

The researcher, Kaikobad Irani, left the school last month with a six-figure settlement, and has a new job lined up, Retraction Watch has learned.

Irani studies the molecular mechanisms of the function and dysfunction of blood vessels. He’s listed as an inventor on four patents, including an active one regarding a compound that could lower the risk of heart attacks and strokes.

One of Irani’s active grants names the Providence VA Medical Center as the awardee organization. A spokesperson for the VA Providence Healthcare System confirmed Irani “is in the process of onboarding and is expected to begin working around November.”

Exclusive: One university’s three-year battle to retract papers with fake data

In 2021, the provost of the University of Maryland, Baltimore sounded the alarm about a troubling batch of papers from the lab of Richard Eckert, the former chair of the Department of Biochemistry and Molecular Biology at the institution.

The provost sent letters to the editors of seven journals calling out a string of serious issues. Based on the university’s investigation, the papers contained duplicated, fabricated and falsified data, according to emails obtained by Retraction Watch.

But more than three years later, the results of those alerts are mixed: Of the 11 papers the university flagged in 2021, editors corrected three and retracted two. Six still await resolution, with no apparent action taken by the journals.

Exclusive: Editor resigns after he says publisher blocked criticism of decision to retract paper on gender dysphoria

A Springer Nature journal has rescinded the acceptance of a paper criticizing the publishing giant’s controversial retraction last year of an article that surveyed parents of children with gender dysphoria, leading an associate editor to resign, Retraction Watch has learned.

According to emails we obtained, the blocked paper was slated to appear as a commentary in a special issue of Springer Nature’s Current Psychology that aimed “to stimulate discussion of all aspects of the ‘unpublication’ of scientific articles.”

“This is the only time I’ve had an accepted paper overruled in 4 years” as an associate editor at this journal, Christopher Ferguson of Stetson University in Florida, one of two guest editors of the special issue, told us by email.

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: